CN108752361A - A kind of preparation method of hydroxycamptothecin - Google Patents
A kind of preparation method of hydroxycamptothecin Download PDFInfo
- Publication number
- CN108752361A CN108752361A CN201810959306.8A CN201810959306A CN108752361A CN 108752361 A CN108752361 A CN 108752361A CN 201810959306 A CN201810959306 A CN 201810959306A CN 108752361 A CN108752361 A CN 108752361A
- Authority
- CN
- China
- Prior art keywords
- preparation
- water
- hydroxycamptothecin
- added
- under reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于合成药物技术领域,具体涉及一种羟基喜树碱的制备方法。The invention belongs to the technical field of synthetic medicines, and in particular relates to a preparation method of hydroxycamptothecin.
背景技术Background technique
10-羟基喜树碱(HCPT)是从珙桐科植物喜树(Camptotheca acuminata)的果实与叶中分离制备的喜树碱十位羟化衍生物,是合成拓扑替康和伊立替康等喜树碱类抗癌药的重要中间体,因此寻找和开发HCPT的制备方法是喜树碱类抗癌药物研发的重要方向之一。目前,制备HCPT的方法有四种:直接提取法、生物转化法、化学全合成法、化学半合成法。2017年岑叶等用超声波-微波协同提取喜树果中HCPT,平均提取率为4.61%。该法消耗大量溶剂,提取工艺复杂,产率较低,大量提取HCPT会对喜树资源造成破坏。2014年王磊等利用喜树内生真菌将喜树碱转化为HCPT,转化率为7.37%,但菌株培养及筛选技术要求高,发酵液里产品浓度低,分离提取步骤繁琐,提取溶剂用量大,技术仍不成熟。2008年Liu等通过Michael加成、分子内羟醛缩合、氧化芳烃化反应、分子内Diels-Alder环加成和Sharpless不对称二羟化反应等系列反应,成功制备了HCPT,其产率为14%,但由于反应步骤多,合成总产率低,有机溶剂用量大,环境污染严重,并且终产物须拆分D/L型异构体,目前无法量产。10-Hydroxycamptothecin (HCPT) is a ten-hydroxylated derivative of camptothecin isolated from the fruit and leaves of Camptotheca acuminata (Camptotheca acuminata). It is an important intermediate of camptothecin anticancer drugs, so finding and developing the preparation method of HCPT is one of the important directions of research and development of camptothecin anticancer drugs. At present, there are four methods for preparing HCPT: direct extraction method, biotransformation method, chemical total synthesis method, and chemical semi-synthesis method. In 2017, Cen Ye et al. used ultrasonic-microwave co-extraction of HCPT in magma fruit, with an average extraction rate of 4.61%. This method consumes a large amount of solvent, the extraction process is complicated, and the yield is low. A large amount of extraction of HCPT will cause damage to the camphor tree resources. In 2014, Wang Lei et al. used camptophytic endophytic fungi to convert camptothecin to HCPT, and the conversion rate was 7.37%. However, the requirements for strain cultivation and screening techniques were high, the concentration of the product in the fermentation broth was low, the separation and extraction steps were cumbersome, and the amount of extraction solvent was large. The technology is still immature. In 2008, Liu et al successfully prepared HCPT through a series of reactions including Michael addition, intramolecular aldol condensation, oxidative aromatication, intramolecular Diels-Alder cycloaddition and Sharpless asymmetric dihydroxylation, with a yield of 14 %, but due to many reaction steps, low synthesis yield, large amount of organic solvents, serious environmental pollution, and the final product must be separated into D/L isomers, it cannot be mass-produced at present.
喜树碱在天然喜树植株中含量约为HCPT的10倍左右,加之喜树碱提取工艺较为成熟,成本相对较低,由此以喜树碱为原料半合成制备HCPT经济合理。现有化学半合成法主要有两种,第一种为喹啉环还原法:首先使用贵重金属将喜树碱催化加氢,还原成1,2,6,7-四氢喜树碱后,再将其氧化制备HCPT;第二种为喹啉环氧化法:先用氧化剂将喜树碱氧化成1-氧喜树碱,再用高压汞灯照射,发生光化学重排,生成HCPT。喹啉环还原法所用贵重金属催化剂成本高,氢化反应安全系数较低,反应条件不易控制。而喹啉环氧化法比喹啉环还原法具有一定的优势,但是,操作复杂,耗时长。The content of camptothecin in natural camptothecin plants is about 10 times that of HCPT. In addition, the extraction process of camptothecin is relatively mature and the cost is relatively low. Therefore, it is economical and reasonable to use camptothecin as a raw material to prepare HCPT semi-synthetically. There are mainly two existing chemical semi-synthetic methods. The first is the quinoline ring reduction method: firstly use precious metals to catalytically hydrogenate camptothecin, and after reducing it to 1,2,6,7-tetrahydrocamptothecin, Then oxidize it to prepare HCPT; the second is the quinoline epoxidation method: first oxidize camptothecin to 1-oxycamptothecin with an oxidant, and then irradiate with a high-pressure mercury lamp to generate HCPT by photochemical rearrangement. The cost of precious metal catalysts used in the quinoline ring reduction method is high, the safety factor of the hydrogenation reaction is low, and the reaction conditions are not easy to control. The quinoline epoxidation method has certain advantages over the quinoline ring reduction method, but the operation is complicated and time-consuming.
发明内容Contents of the invention
本发明的目的是对化学半合成羟基喜树碱的喹啉环氧化法进行改进,解决现有技术耗时长、安全系数低、反应操作不便的问题,建立一种便捷、高效、绿色环保的新方法。The purpose of the present invention is to improve the quinoline epoxidation method of chemical semi-synthesis of hydroxycamptothecin, solve the problems of time-consuming, low safety factor, and inconvenient reaction operation in the prior art, and establish a convenient, efficient, and environmentally friendly new method.
一种羟基喜树碱的制备方法,包括以下步骤:A preparation method for hydroxycamptothecin, comprising the following steps:
(1)N-氧化反应(1) N-oxidation reaction
喜树碱水浴加热,在30-45℃时,加入酸溶剂,搅拌溶解喜树碱;匀速升温至60-70℃,加入氧化剂过硼酸钠,继续搅拌并冷凝回流;持续反应,待反应结束,停止加热,自然冷却至室温;Heating the camptothecin in a water bath, at 30-45°C, add an acid solvent, stir and dissolve the camptothecin; raise the temperature to 60-70°C at a constant speed, add the oxidant sodium perborate, continue to stir and condense and reflux; continue the reaction, and wait until the reaction is over, Stop heating and cool down to room temperature naturally;
减压浓缩反应液,向浓缩液中加入冰水,静置结晶;待晶体完全析出后,过滤,蒸馏水洗涤,干燥,即得1-氧喜树碱;Concentrate the reaction solution under reduced pressure, add ice water to the concentrated solution, and let it stand for crystallization; after the crystals are completely precipitated, filter, wash with distilled water, and dry to obtain 1-oxocamptothecin;
其中酸溶剂为冰乙酸、甲酸,优选冰乙酸;喜树碱质量与冰乙酸体积之比为1:50-1:200,优选1:100;喜树碱与过硼酸钠的物质的量之比为1:10-1:70,优选1:45;反应温度为70-120℃,优选90℃;反应时间为30-100min,优选50min。Wherein the acid solvent is glacial acetic acid, formic acid, preferably glacial acetic acid; the ratio of camptothecin quality to glacial acetic acid volume is 1:50-1:200, preferably 1:100; the ratio of the amount of camptothecin to sodium perborate 1:10-1:70, preferably 1:45; the reaction temperature is 70-120°C, preferably 90°C; the reaction time is 30-100min, preferably 50min.
(2)光化重排(2) Actinic rearrangement
将上述步骤制得的1-氧喜树碱加入二噁烷、乙腈、水以及浓硫酸溶解并搅拌,用紫外高压汞灯光照,冰水冷凝回流;Add dioxane, acetonitrile, water and concentrated sulfuric acid to the 1-oxocamptothecin prepared in the above steps to dissolve and stir, illuminate with ultraviolet high-pressure mercury lamp, and condense and reflux with ice water;
待反应结束,停止光照,自然冷却至室温;减压浓缩,向反应液中加入大量冰水,静置结晶;待晶体完全析出后,过滤,蒸馏水洗涤,干燥,即得HCPT粗品;After the reaction is completed, stop the light, and cool naturally to room temperature; concentrate under reduced pressure, add a large amount of ice water to the reaction solution, and let it stand for crystallization; after the crystals are completely precipitated, filter, wash with distilled water, and dry to obtain crude HCPT;
其中二噁烷、乙腈和水的体积之比为5:3:1,水为蒸馏水,浓硫酸与蒸馏水体积之比为1:70-1:120,优选1:100,1-氧喜树碱与蒸馏水质量之比为1:50-1:150优选1:100,紫外高压汞灯功率为400-700W,优选500W,光照时间为40-80min,优选60min。反应方程式:Wherein the volume ratio of dioxane, acetonitrile and water is 5:3:1, water is distilled water, the volume ratio of concentrated sulfuric acid and distilled water is 1:70-1:120, preferably 1:100, 1-oxocamptothecin The ratio to the quality of distilled water is 1:50-1:150, preferably 1:100, the power of the ultraviolet high-pressure mercury lamp is 400-700W, preferably 500W, and the illumination time is 40-80min, preferably 60min. Reaction equation:
(3)粗品纯化(3) crude product purification
常压玻璃层析柱,以硅胶填充。色谱柱高度为150~200mm,色谱柱直径为250mm,样品与硅胶的质量比为1:50-1:100,优选1:100。使用三氯甲烷湿法装柱,随后用乙醇将上述步骤制备的HCPT粗产品溶解,拌入少量硅胶干法上样。甲醇:三氯甲烷体积比为1:30-1:70,优选1:49作为流动相等度洗脱,使用试管收集并编号,TLC监测产物纯度,检测后合并相似的馏分,将HCPT含量超过98.5%的合并液,经减压蒸馏、真空干燥后得到产品;将低于该含量的合并液经减压浓缩至刚好有固体析出,把浓缩液放到冰箱静置过夜,过滤、将固体真空干燥后得到98.5%以上的纯品,总产率为86.42%。Atmospheric pressure glass chromatography column, filled with silica gel. The height of the chromatographic column is 150-200mm, the diameter of the chromatographic column is 250mm, and the mass ratio of sample to silica gel is 1:50-1:100, preferably 1:100. Use chloroform to wet-pack the column, then dissolve the crude HCPT product prepared in the above steps with ethanol, and add a small amount of silica gel for dry loading. The volume ratio of methanol: chloroform is 1:30-1:70, preferably 1:49 as the flow equality elution, use test tubes to collect and number, TLC to monitor the product purity, after detection, merge similar fractions, and the HCPT content exceeds 98.5 % of the combined solution, the product was obtained after vacuum distillation and vacuum drying; the combined solution lower than this content was concentrated under reduced pressure until a solid was precipitated, and the concentrated solution was placed in the refrigerator to stand overnight, filtered, and the solid was vacuum-dried After obtaining more than 98.5% pure product, the total yield is 86.42%.
本发明的技术效果:Technical effect of the present invention:
(1)本发明采用过硼酸钠作为氧化剂制备1-氧喜树碱,缩短了氧化反应时间,提高了氧化反应产率。(1) The present invention uses sodium perborate as an oxidizing agent to prepare 1-oxocamptothecin, which shortens the oxidation reaction time and improves the oxidation reaction yield.
(2)本发明以1,4,-二氧六环、乙腈、水体积比为5:3:1的混合溶剂为光化溶剂,提高了光化反应转化率。(2) The present invention uses a mixed solvent of 1,4,-dioxane, acetonitrile, and water with a volume ratio of 5:3:1 as the photochemical solvent, which improves the conversion rate of the photochemical reaction.
(3)本发明实验操作简单,安全经济,绿色环保,总产率高,达到86.42%。(3) The experimental operation of the present invention is simple, safe and economical, environmentally friendly, and the total yield is high, reaching 86.42%.
附图说明Description of drawings
图1为实施例的产物1-氧喜树碱质谱图;Fig. 1 is the product 1-oxycamptothecin mass spectrogram of embodiment;
图2为实施例的产物10-羟基喜树碱的1H-NMR;Fig. 2 is the 1 H-NMR of the product 10-hydroxycamptothecin of embodiment;
图3为实施例的产物10-羟基喜树碱的13C-NMR。Fig. 3 is the 13 C-NMR of the product 10-hydroxycamptothecin in the example.
具体实施方式Detailed ways
结合实施例说明本发明的具体技术方案。The specific technical solutions of the present invention are described in conjunction with the examples.
羟基喜树碱的制备方法,包括以下步骤:The preparation method of hydroxycamptothecin comprises the following steps:
(1)N-氧化反应(1) N-oxidation reaction
精密称定适量喜树碱,将其置于圆底烧瓶中。水浴加热,在30-45℃时,加入酸溶剂,搅拌10min,溶解喜树碱。匀速升温至60-70℃,加入氧化剂过硼酸钠,继续搅拌并冷凝回流。升温持续反应。待反应结束,停止加热,自然冷却至室温。减压浓缩反应液,向浓缩液中加入大量冰水,静置结晶。待晶体完全析出后,过滤,少量蒸馏水洗涤,干燥,即得1-氧喜树碱,产率为96.46%。Accurately weigh an appropriate amount of camptothecin and place it in a round bottom flask. Heating in a water bath, at 30-45°C, add an acid solvent, stir for 10 minutes, and dissolve camptothecin. Raise the temperature to 60-70°C at a constant speed, add the oxidizing agent sodium perborate, continue to stir and condense to reflux. The temperature rises and the reaction continues. After the reaction was completed, the heating was stopped and cooled to room temperature naturally. The reaction liquid was concentrated under reduced pressure, a large amount of ice water was added to the concentrated liquid, and the crystallization occurred upon standing. After the crystals are completely precipitated, filter, wash with a small amount of distilled water, and dry to obtain 1-oxocamptothecin with a yield of 96.46%.
其中酸溶剂为冰乙酸;喜树碱质量与冰乙酸体积之比为1:100;喜树碱与过硼酸钠的物质的量之比为1:45;反应温度为90℃;反应时间为50min。Wherein the acid solvent is glacial acetic acid; the ratio of the mass of camptothecin to the volume of glacial acetic acid is 1:100; the ratio of the amount of substances of camptothecin to sodium perborate is 1:45; the reaction temperature is 90°C; the reaction time is 50min .
(2)光化重排(2) Actinic rearrangement
将上述步骤制得的1-氧喜树碱置于1000mL光化学反应瓶中,再加入二噁烷、乙腈、水以及浓硫酸溶解并搅拌,用紫外高压汞灯光照,冰水冷凝回流。待反应结束,停止光照,自然冷却至室温。减压浓缩,向反应液中加入大量冰水,静置结晶。待晶体完全析出后,过滤,少量蒸馏水洗涤,干燥,即得HCPT粗品。其中二噁烷、乙腈和水的体积之比为5:3:1,浓硫酸与蒸馏水体积之比为1:100,1-氧喜树碱与蒸馏水质量之比为1:100,紫外高压汞灯功率为500W,光照时间60min。Put the 1-oxocamptothecin prepared in the above steps into a 1000mL photochemical reaction bottle, then add dioxane, acetonitrile, water and concentrated sulfuric acid to dissolve and stir, illuminate with ultraviolet high-pressure mercury lamp, and condense and reflux with ice water. After the reaction was completed, the light was stopped and cooled to room temperature naturally. Concentrate under reduced pressure, add a large amount of ice water to the reaction liquid, and let it stand for crystallization. After the crystals are completely precipitated, filter, wash with a small amount of distilled water, and dry to obtain crude HCPT. The volume ratio of dioxane, acetonitrile and water is 5:3:1, the volume ratio of concentrated sulfuric acid to distilled water is 1:100, the ratio of 1-oxocamptothecin to distilled water is 1:100, and the ultraviolet high pressure mercury The lamp power is 500W, and the illumination time is 60min.
(3)柱色谱纯化(3) Column chromatography purification
常压玻璃层析柱,以硅胶填充。色谱柱高度为150~200mm,色谱柱直径为250mm,样品与硅胶的质量比为1:100。使用三氯甲烷湿法装柱,随后用乙醇将上述步骤制备的HCPT粗产品溶解,拌入少量硅胶干法上样。甲醇:三氯甲烷体积比为1:49作为流动相等度洗脱,使用试管收集并编号,TLC监测产物纯度,检测后合并相似的馏分,将HCPT含量超过98.5%的合并液,经减压蒸馏、真空干燥后得到产品;将低于该含量的合并液经减压浓缩至刚好有固体析出,把浓缩液放到冰箱静置过夜,过滤、将固体真空干燥后得到98.5%以上的纯品,总产率为86.42%。Atmospheric pressure glass chromatography column, filled with silica gel. The height of the chromatographic column is 150-200mm, the diameter of the chromatographic column is 250mm, and the mass ratio of sample to silica gel is 1:100. Use chloroform to wet-pack the column, then dissolve the crude HCPT product prepared in the above steps with ethanol, and add a small amount of silica gel for dry loading. Methanol: trichloromethane volume ratio is 1:49 as mobile equivalence elution, use test tubes to collect and number, TLC to monitor product purity, after detection, combine similar fractions, and the combined solution with HCPT content exceeding 98.5% is distilled under reduced pressure , to obtain the product after vacuum drying; the combined solution lower than this content is concentrated under reduced pressure until just solids are precipitated, the concentrated solution is placed in the refrigerator to stand overnight, filtered, and the solids are vacuum-dried to obtain more than 98.5% pure product, The total yield is 86.42%.
对以上所得的产物鉴别:Identification of the products obtained above:
(1)N-氧化反应产物:(1) N-oxidation reaction product:
1-氧喜树碱为黄色固体,使用液质联用鉴别,如图1。色谱条件:Agilent 1290高效液相色谱柱(ACQUITY UPLC BEH C18,2.1×100mm,1.7μm)分离,柱温30℃,流速0.3mL/min;进样量0.1μl;流动相组成A:水+0.1%甲酸,B:乙腈;梯度洗脱程序:1-18min,5-50%(B),18-25min,50-80%(B),25-28min,80-98%(B),28-33min,98-98%(B)。检测波长373nm。1-氧喜树碱鉴别使用Waters Xevo G2-XS QTOF,ESI正离子模式,质量扫描范围为m/z:50-1000。HRMS m/z365.1814[M+H]+(calcd for C20H16N2O5,364.3510)。1-Oxycamptothecin is a yellow solid, identified by liquid chromatography-mass spectrometry, as shown in Figure 1. Chromatographic conditions: Agilent 1290 HPLC column (ACQUITY UPLC BEH C 18 , 2.1×100mm, 1.7μm) separation, column temperature 30°C, flow rate 0.3mL/min; injection volume 0.1μl; mobile phase composition A: water + 0.1% formic acid, B: acetonitrile; Gradient elution program: 1-18min, 5-50%(B), 18-25min, 50-80%(B), 25-28min, 80-98%(B), 28 -33 min, 98-98% (B). The detection wavelength is 373nm. 1-Oxycamptothecin was identified using Waters Xevo G2-XS QTOF, ESI positive ion mode, and the mass scanning range was m/z:50-1000. HRMS m/z 365.1814 [M+H] + (calcd for C 20 H 16 N 2 O 5 , 364.3510).
(2)光重排反应产物:(2) Photorearrangement reaction products:
10-羟基喜树碱,淡黄色固体,mp:264.4-265.6℃。核磁共振氢谱如图2、核磁共振碳谱数如图3;240(15272),250(10706),255(15008),260(16376),267(24885),273(21642),281(4977),286(5957),292(5478),297(5635),316(7999),332(10171),370(20037),385(23260);IR(KBr):3520,3095,2897,1722,1653,1594,1553,1505,1336,1262,1173,1049,836,746,669cm-1;1H-NMR(400MHz,DMSO-d6):δ0.88(t,J=8Hz,3H),1.85-1.88(t,2H),5.23(s,2H),5.41(s,2H),6.48(s,1H),7.26(s,1H),7.28(d,J=4Hz,1H),7.41-7.44(dd,J1=4Hz,J2=8Hz,1H),8.03(d,J=8Hz,1H),8.45(s,1H),10.32(s,1H);13C-NMR(400MHz,DMSO-d6):δ8.20,30.68,50.56,65.67,72.83,96.26,109.23,118.56,123.46,129.71,130.10,130.35,131.08,143.65,146.34,149.85,150.48,157.09,157.28,172.94;HRMS m/z365.1814[M+H]+(calcd for C20H16N2O5,364.3510)。10-Hydroxycamptothecin, pale yellow solid, mp: 264.4-265.6°C. The H NMR spectrum is shown in Figure 2, and the C NMR spectrum is shown in Figure 3; 240(15272),250(10706),255(15008),260(16376),267(24885),273(21642),281(4977),286(5957),292(5478),297(5635), 316(7999),332(10171),370(20037),385(23260);IR(KBr):3520,3095,2897,1722,1653,1594,1553,1505,1336,1262,1173,1049,836,746,669 cm -1 ; 1 H-NMR (400MHz, DMSO-d 6 ): δ0.88(t, J=8Hz, 3H), 1.85-1.88(t, 2H), 5.23(s, 2H), 5.41(s, 2H), 6.48(s, 1H), 7.26(s, 1H), 7.28(d, J=4Hz, 1H), 7.41-7.44(dd, J 1 =4Hz, J 2 =8Hz, 1H), 8.03(d , J=8Hz, 1H), 8.45(s, 1H), 10.32(s, 1H); 13 C-NMR (400MHz, DMSO-d 6 ): δ8.20, 30.68, 50.56, 65.67, 72.83, 96.26, 109.23 ,118.56,123.46,129.71,130.10,130.35,131.08,143.65,146.34,149.85,150.48,157.09,157.28,172.94; HRMS m/ z365.1814 [M+H] + ( calcd for C 22 H 56 N ,364.3510).
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810959306.8A CN108752361A (en) | 2018-08-22 | 2018-08-22 | A kind of preparation method of hydroxycamptothecin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810959306.8A CN108752361A (en) | 2018-08-22 | 2018-08-22 | A kind of preparation method of hydroxycamptothecin |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108752361A true CN108752361A (en) | 2018-11-06 |
Family
ID=63967304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810959306.8A Pending CN108752361A (en) | 2018-08-22 | 2018-08-22 | A kind of preparation method of hydroxycamptothecin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108752361A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074256A1 (en) * | 1981-09-04 | 1983-03-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives, processes for preparing same, formulations containing such derivatives and their use |
-
2018
- 2018-08-22 CN CN201810959306.8A patent/CN108752361A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074256A1 (en) * | 1981-09-04 | 1983-03-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives, processes for preparing same, formulations containing such derivatives and their use |
Non-Patent Citations (1)
Title |
---|
战佩英等: "N-氧化吡啶合成新方法的探索", 《通化师范学院学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102040520A (en) | Method for separating and purifying chlorogenic acid from eucommia bark leaves | |
CN101811950A (en) | Industrialized production method of high-purity xanthohumol | |
CN114988979B (en) | Method for preparing high-purity lycopene by macro separation | |
CN103087142B (en) | A kind of method extracting Tripterine | |
CN111333660B (en) | 550nm excited rhodamine dye and preparation method thereof | |
CN108752361A (en) | A kind of preparation method of hydroxycamptothecin | |
CN109776474A (en) | A kind of method for separating and purifying flavonoids from wild horse chasing | |
CN106008445A (en) | Flavone and lignin compound and extracting method thereof | |
CN105017273A (en) | Method for extracting, separating and purifying psoralen and isopsoralen from fructus psoraleae | |
CN105384746B (en) | The method that ungernine is extracted from the bulb of vegetation water ghost any of several broadleaf plants | |
TW201918467A (en) | Method of purifying kirenol | |
CN111018819B (en) | Preparation method of luteolin | |
CN104356141B (en) | A kind of ginkgolides L preparation method | |
CN108129545A (en) | A kind of method for preparing triptolide | |
CN114891052B (en) | A method for preparing 1,2,3,6-tetra-O-galloyl-β-D-pyranoglucoside from oil-tea camellia | |
CN104101661A (en) | Quick detecting method for sudan red in food | |
CN111334070B (en) | 532nm excited rhodamine fluorescent dye and preparation method thereof | |
CN101220036B (en) | Extraction of active ingredient such as betulinic acid from common camptotheca fruit with clean method | |
CN108484428B (en) | A kind of amide compound and amide compound component in wolfberry and preparation method thereof | |
CN108276263B (en) | Method for preparing free gossypol by using gossypol acetate as raw material | |
CN102786472B (en) | Method for extraction separation of huperzine A in all-grass of snake foot clubmoss and its hairy root by supercritical extraction-crystallization technology | |
CN107163017B (en) | A kind of preparation process of tetramethylrhodamine | |
CN107353296B (en) | A method of extracting activated protein and eurycomanone from Tongkat Ali | |
CN103421054A (en) | Preparation method of phyllaemblicin B | |
CN104804011A (en) | Method for separating and purifying isoimperatorin and imperatorin from angelica dahurica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181106 |
|
RJ01 | Rejection of invention patent application after publication |